We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Life After Prostate Surgery Worse Than Expected

By HospiMedica International staff writers
Posted on 19 Jul 2011
A new study has found that nearly half of men who undergo surgery for prostate cancer find themselves with greater incontinence problems and less sexual function than they anticipated. More...


Researchers at the University of Michigan (Ann Arbor, USA) polled 152 consenting patients undergoing radical prostatectomy (RP) between June 2007 and November 2008, who were extensively counseled preoperatively regarding expected urinary, bowel, hormonal and sexual function outcomes. They were assessed once at baseline and again one year after surgery using the short form of the Expanded Prostate Index Composite (EPIC); baseline expectations of functional outcomes one year after surgery were assessed using the EPIC-Expectations. The associations between EPIC-Expectations and EPIC-Short Form at baseline were then compared.

The results showed that the on the follow-up survey one year later, just 36% of the men said their expectations for urinary function matched the true outcomes, and 40% said their expectations for sexual function matched reality. Fewer than 22% of the patients attained lower than expected urinary irritable symptoms, and bowel and hormonal function. On the other hand, 12% of the patients expected better than baseline urinary incontinence, and 17% of patients expected better sexual function at one year after surgery, a belief the researchers say is out of step with reality. The study was published early online on June 15, 2011, in the Journal of Urology.

“It's hard to predict how likely a patient is to recover his urinary and sexual function. We can only inform them in terms of overall statistics, we can't predict for the individual man how well he will recover,” said lead author social worker Daniela Wittmann, ACSW, MSW, the sexual health coordinator at the University of Michigan urology department. “This means that if in doubt, people tend towards being hopeful and optimistic.”

Even with significant advances in surgical technique and superb results for cancer control and preservation of urinary function, erectile dysfunction following RP is a common complication. This is mainly attributed to temporary cavernous nerve damage (neuropraxia) resulting in penile hypoxia, smooth muscle apoptosis, fibrosis, and veno-occlusive dysfunction.

Related Links:

University of Michigan




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.